Likewise, the different pathways of IL-1β activation demonstrated here may be studied as a parameter of pharmacological intervention in order to prevent the evolution of cardiomyopathy, fibrosis and inflammation in the pathogenesis of Chagas disease. This evidence concerns the gene IL1B and cardiomyopathy.